Sun, Dec 21, 2014, 2:08 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Cubist Pharmaceuticals Inc. Message Board

  • paggap2000 paggap2000 Apr 26, 2012 2:43 PM Flag

    Adolor contingency payment

    What is happening to those Adolor contingency payments ?

    Any progress with FDA ?

    Thanks

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • bump

      • 1 Reply to cellmaverick
      • The terms:
        $1.25 per CPR payable if ADL5945 receives FDA approval for the treatment of chronic opioid induced constipation on or before July 1, 2019.
        An additional $1.75 per CPR payable if such FDA approval meets certain safety, efficacy, and timing criteria. This relates principally to ADL5945 having a clean, non-restrictive label.
        $0.50 payable if ADL5945 receives centralized EU approval for the treatment of OIC on or before July 1, 2019.
        An additional $1.00 per CPR payable if such centralized EU approval meets certain safety, efficacy, and timing criteria. This relates principally to ADL5945 having a clean, non-restrictive label.
        If, as of July 1, 2019, the Additional FDA Payment has not been earned, up to $1.75 per CPR payable if certain commercial milestones for ADL5495 are reached; and
        If, as of July 1, 2019, the Additional EMA Payment has not been earned, up to $1.00 per CPR payable if certain commercial milestones for ADL5495 are reached.

        Found this:
        Quotes via SeekingAlpha re CB-5945 (formerly ADL-5945)
        Phase 3 program to start by year-end 2012 - CBST would not reveal the cost of the program.
        Partnering discussions ongoing, no commitment regarding whether to partner before or after seeing phase 3 data.

        Have to watch news from cubist on cb 5945 although there's not much we can do but watch.

 
CBST
98.67+0.90(+0.92%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Under Armour, Inc.
NYSEFri, Dec 19, 2014 4:04 PM EST
ImmunoGen, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST
3M Company
NYSEFri, Dec 19, 2014 4:04 PM EST